Stockreport

Dyne stock tumbles 31% amid drug updates, management changes [Seeking Alpha]

Edgewise Therapeutics, Inc.  (EWTX) 
PDF skipping demonstrated “unprecedented dystrophin expression and functional improvement in multiple cohorts,” according to a statement Dyne also announced that its chief [Read more]